The clinical significance of CN0 lies in its potential association with Kallmann syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism (HH) and hyposmia or anosmia in both sexes. Research suggests that disruptions in the normal migration of basal forebrain GnRH cells during embryonic development may lead to the hypogonadism observed in KS (
27). Additionally, mutations in the kisspeptin 1 gene (KISS1), which can result in hypogonadotropic hypogonadism or precocious puberty, are noteworthy (
28). This gene is expressed in the central nervous system (CNS), particularly in the hypothalamus, but also in regions such as the amygdala, caudate, cingulate, globus pallidus, hippocampus, medial and superior frontal gyri, nucleus accumbens, parahippocampal gyrus, substantia nigra, putamen, and thalamus (
29). Furthermore, kisspeptin plays a crucial role in fear, anxiety, reward pathways, negative emotions, and olfaction, potentially influencing syndromes related to CNS structures and mood (
30).